Search
Patexia Research
Case number 2021-1633

Roche Diagnostics Corporation v. Meso Scale Diagnostics, LLC > Documents

Date Field Doc. No.Description (Pages)
May 16, 2022 9 Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [849891] [21-1609, 21-1633]. --[Edited 05/16/2022 by MVH to correct originating tribunal section] [MVH] [Entered: 05/16/2022 10:29 AM] (1)
Apr 8, 2022 7 OPINION filed for the court by Newman, Circuit Judge; Prost, Circuit Judge and Taranto, Circuit Judge. Newman, Circuit Judge, dissenting. Precedential Opinion. Service as of this date by the Clerk of Court. [841884] [21-1609, 21-1633] [MVH] [Entered: 04/08/2022 10:24 AM] (38)
Apr 8, 2022 8 JUDGMENT. AFFIRMED-IN-PART, REVERSED-IN-PART, VACATED-IN-PART, AND REMANDED. Terminated on the merits after oral argument. COSTS: Each Side Bears Its Own Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [841887] [21-1609, 21-1633] [MVH] [Entered: 04/08/2022 10:25 AM] (1)
Feb 19, 2021 6 NOTICE OF NON-COMPLIANCE: The submission of Appellees BioVeris Corporation and Roche Diagnostics Corporation, Entry of Appearance, Docketing Statement, Certificate of Interest [3], [4], [5], is not in compliance with the rules of this court (see attached). Service as of this date by the Clerk of Court. [757263] [KMH] [Entered: 02/19/2021 09:15 AM] (1)
Feb 16, 2021 3 Entry of appearance for James T. McKeown; Jeffrey N. Costakos; Kimberly K. Dodd as counsel for Appellees BioVeris Corporation and Roche Diagnostics Corporation. Service: 02/16/2021 by email. [756480] [21-1633] [James McKeown] [Entered: 02/16/2021 05:26 PM] (2)
Feb 16, 2021 4 Certificate of Interest for Appellees BioVeris Corporation and Roche Diagnostics Corporation. Service: 02/16/2021 by email. [756481] [21-1633] [James McKeown] [Entered: 02/16/2021 05:28 PM] (3)
Feb 16, 2021 5 Docketing Statement for the Appellees BioVeris Corporation and Roche Diagnostics Corporation. Service: 02/16/2021 by email. [756482] [21-1633] [James McKeown] [Entered: 02/16/2021 05:29 PM] (2)
Feb 8, 2021 1 Appeal docketed. Received: 02/03/2021. [754404]. [KMH] [Entered: 02/08/2021 10:08 AM] (78)
Feb 8, 2021 2 Note to File: The following cases are consolidated: 21-1609 Lead with 21-1633 Cross-Appeal. The parties must file all documents in the lead appeal only. [754407] [21-1609, 21-1633] [KMH] [Entered: 02/08/2021 10:13 AM] (0)
Menu